As a growing number of overweight Americans clamor for Ozempic and Wegovy — drugs touted by celebrities and on TikTok to pare pounds — an even more powerful obesity medicine is poised to upend treatment
.
Based on the new results, which have not yet been published in full, company officials said they will finalize an application to the U.S. Food and Drug Administration for fast-track approval to sell tirzepatide for chronic weight management. A decision could come later this year. A company spokeswoman would not confirm whether the drug would be marketed for weight loss in the U.S. under a different brand name.
In separate trials, tirzepatide has resulted in greater weight loss than semaglutide, whose users shed about 15% of their body weight over 16 months. A head-to-head trial comparing the two drugs is planned. Rather than relying solely on diet, exercise and willpower to reduce weight, tirzepatide and other new drugs target the digestive and chemical pathways that underlie obesity, suppressing appetite and blunting cravings for food.
“That is a real physical phenomenon,” Aronne said. “There are a number of hormones that respond to reduced calorie intake.”
Argentina Últimas Noticias, Argentina Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Powerful new obesity drug poised to upend weight loss careAs a growing number of overweight Americans clamor for Ozempic and Wegovy — drugs touted by celebrities and on TikTok to pare pounds — an even more powerful obesity medicine is poised to upend treatment.
Leer más »
Medicare coverage could change with weight loss medication OzempicInsider tells the global tech, finance, markets, media, healthcare, and strategy stories you want to know.
Leer más »
6 Ozempic facts that make sense of social media hypeSix weight loss drugs facts that you need to know, including how Ozempic works and common Ozempic side effects.
Leer más »
Eli Lilly Pushes For Fast-Track Approval Of Mounjaro As Weight-Loss DrugLate-stage trials suggest Lilly’s tirzepatide, sold under Mounjaro, could be a more effective obesity drug that Ozempic or Wegovy, and the company expects a regulatory decision by the end of the year.
Leer más »
Many Americans ordered free COVID tests, didn't use them right awayThe Centers for Disease Control and Prevention released data showing how many of the government's free COVID-19 tests went to use.
Leer más »
Americans are getting worried about the job market | CNN BusinessUS consumer confidence worsened in April as Americans become more pessimistic about the job market.
Leer más »